When to Confirm a Positive NAAT An additional test should be considered after a positive screening test if a false-positive screening test would result.

Slides:



Advertisements
Similar presentations
Analytical Sensitivity of the Urine-Based APTIMA® Trichomonas vaginalis molecular assay using the automated Tigris® Platform A.H. Freeman1, M.W. Pandori2,
Advertisements

John Harrison, Michelle Garassi, Sara Wierzbicki, William LeBar Hospital Consolidated Laboratories-Providence Hospital, Southfield, MI, Evaluation of the.
PREVALENCE OF CHLAMYDIA TRACHOMATIS, NEISSERIA GONORRHOEAE AND TRICHOMONAS VAGINALIS IN YOUNG WOMEN IN KENYA USING THE GEN-PROBE APTIMA ASSAYS J Moncada.
Chlamydia and Gonorrhea Infections at the Time of a Positive RPR in STD Clinic Patients S.S. Philip, J.L. Marcus, J. Engelman, K.T. Bernstein, J.D. Klausner.
John Harrison, Michelle Garassi, Sara Wierzbicki, William LeBar Hospital Consolidated Laboratories-Providence Hospital, Southfield, MI, Abstract There.
Nick Curry, MD, MPH Infectious Diseases Prevention Section
Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
Prevalence of Chlamydia trachomatis and Neisseria gonorrhea infection by anatomic site in a cohort study of men who have sex with men (MSM) in Bangkok,
Transmission of Chlamydia trachomatis between heterosexual sex partners PRELIMINARY RESULTS FROM A GENOTYPE-SPECIFIC CONCORDANCE STUDY.
Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD.
Confirmatory Testing of NAATs SHOULD be Routine for Chlamydia Infections in Populations with < 4% Prevalence Harold C. Wiesenfeld, M.D.,C.M. University.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
CDC Laboratory Update  Chlamydia and Gonorrhea Laboratory Guidelines  Overview of the APHL / CDC STD Steering Committee.
A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
6/03/031 Hepatitis C –Update Laboratory Issues Hema Kapoor MD. SM Virology Section Manager Bureau of Laboratories Michigan Department of Community Health.
Positive NAAT test results for Neisseria gonorrhoeae do not require routine confirmatory testing Matthew R. Golden MD, MPH Center for AIDS & STD, University.
Self-Collected Vaginal Specimens for the Detection of Multiple STIs in Adolescent Detainees Cynthia M. Holland, M.D., M.P.H., Harold C. Wiesenfeld, M.D.,
Epidemiology of Chlamydia in the United States Debra J. Mosure, Ph.D. Division of STD Prevention Centers for Disease Control and Prevention March 8, 2004.
What Happens to the Performance of a Diagnostic Test when the Disease Prevalence and the Cut-Point Change? Pathological scores Healthy scores Healthy population.
CDC National Infertility Prevention Project Laboratory Update Region I Wells Beach, Maine June 1-3, 2009 Richard Steece, Ph.D., D(ABMM)
Hyperbilirubinemia: Discussion Alexis Thompson, MD Catherine Wicklund, MS, CGC.
STI testing in Europe, accessibility and availability I. Sziller 1 st Dept. Obstetrics and Gynecology, Semmelweis University Medical School.
Chlamydia Sexually Transmitted Disease Surveillance 2000 Division of STD Prevention.
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
The laboratory investigation of urinary tract infections
Chlamydia Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.
Guidelines for Laboratory Testing and Result Reporting for Antibody to Hepatitis C Virus Miriam J. Alter, Ph.D. Division of Viral Hepatitis Centers for.
Evaluation of Gonorrhea Screening in Family Planning Settings: California 2000 CK Kent, M Brammeier, G Bolan, N Casas, M Funabiku, P Blackburn Region IX.
HIV Rapid Testing Dr. Kevin Harvey National HIV/AIDS Programme Ministry of Health Jamaica.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
Los Angeles County STD Surveillance Data Surveillance, Sources, Methods and Issues Lisa V. Smith, MS, DrPH Director, Epidemiology Unit Los Angeles County.
Sexually Transmitted Disease (STD) Surveillance Report, 2009 Minnesota Department of Health STD Surveillance System Minnesota Department of Health STD.
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
Trends in Clinic Visits and Diagnosed C. trachomatis and N. gonorrhoeae Infections Following the Introduction of a Co-Pay in an STD Clinic C. Rietmeijer.
Region I Laboratory Update CDC National Infertility Prevention Project Boston, Massachusetts November 15, 2010 Richard Steece, Ph.D., D(ABMM) Laboratory.
The Impact of Introducing “Express Visits” for Asymptomatic Persons Seeking STD Services in a Busy Urban STD Clinic System, Borrelli J 1, Paneth-Pollak.
Risk factors of sexually transmitted infection (STI) and their relationship with HIV among female sex workers (FSW) in Nagaland: A high HIV prevalence.
Lower Hudson Valley Perinatal Network Serving Dutchess, Putnam, Rockland & Westchester Counties Presented at the Quarterly Education & Networking Conference.
Evaluation of Presumptive Treatment Recommendation for Asymptomatic Anorectal Gonorrhoea and Chlamydia Infections in At-Risk Kenyan MSM IAS 24 July 2012.
Practical application. Population A ELISA test is applied to a million people where 1% are infected with HIV. Of the million people, 10,000 would be infected.
Sexual History Ejay Harris. Where to start? WIPE Open ended question……vaginal discharge.
Sexually Transmitted Infections in Europe, 2012 European Centre for Disease Prevention and Control.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Sexual Health Data in Leicestershire, Leicester City and Rutland Janet Hutchins and Liz Rodrigo.
Review of Gonorrhoea (GC) Contacts Gay Men’s Health Service 2012 / 2013 Louise PomeroyMick QuinlanSusan Clarke GMHSGMHSSJH / GMHS 9 th November 2013.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
1 Disaster epidemiology Professor Vilius Grabauskas Kaunas University of Medicine, Kaunas, Lithuania NATO supported advanced research workshop, Kaunas,
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Risk Behaviour, Health Care Access and Prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoea in a population based sample of.
Vaginal Swabs Clinical Information Why? Murray Robinson
Emily Weston, MPH 2016 Annual CSTE Meeting
Copyright © 2008 American Medical Association. All rights reserved.
It's not what you know, but who you know: Risk factors for re-infection in the Philadelphia High School STD Screening Program Jennifer Beck, MPH APHA.
Richard Steece, Ph.D., D(ABMM)
How do we delay disease progress once it has started?
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
How do we judge efficacy of a screening test?
بعض النقاط التي تؤخذ في الحسبان عند تقييم الاستثمارات الزراعية
Large-scale testing of women in Copenhagen has not reduced the prevalence of Chlamydia trachomatis infections  H. Westh, H.J. Kolmos  Clinical Microbiology.
Positive predictive value of screening tests
The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.
A retrospective study into the prevalence of herpes simplex virus 1&2 in female patients tested for Chlamydia trachomatis and/or Neisseria gonorrhoeae.
Volume 351, Pages S25-S28 (June 1998)
Impact of pads and cups on school dropout, sexually transmitted infections (STIs) and reproductive tract infections (RTIs) by 9 months duration. §Adjusted.
Finding Sex Partners On-Line: What’s the Risk for STI
Impact of pads and cups on school dropout, STI and RTI
Nucleic Acid Amplification Tests for the Diagnosis of Chlamydia trachomatis Rectal Infections Bachmann LH1,2, Johnson R3, Cheng H1, Markowitz L3, Papp.
Presentation transcript:

When to Confirm a Positive NAAT An additional test should be considered after a positive screening test if a false-positive screening test would result in substantial adverse medical, social, or psychological impact for a patient. Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections-2002, MMWR 2002; 51 (No. RR-15): 14

NAATs Confirmation Recommendation Consideration should be given to routine additional testing for persons with positive C. trachomatis or N. gonorrhoeae screening tests when risk factor information or actual surveys indicate that the prevalence is low, resulting in a lower PPV (e.g., <90%) Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections-2002, MMWR 2002; 51 (No. RR-15): 14

Interactions Between Specificity and PPV Specificity = 99.5% Sensitivity = 90.0% (top) Sensitivity = 80.0% (bottom) Specificity = 99.0% Sensitivity = 90.0% (top) Sensitivity = 80.0% (bottom)

NAATs Confirmation Recommendation Only another NAAT is sufficiently sensitive to be used as a confirmatory test for a NAAT Note: Such an approach has received only limited evaluation. Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections- 2002, MMWR 2002; 51 (No. RR-15): 14

Controversies In STD Diagnostics Confirmatory Testing Is Required For Positive NAATs for Chlamydia and Gonoccocal Infections in Populations with less than 4% prevalence